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Intra-operative tumor rupture is a serious complication during resection of large hepatocellular carcinoma (HCC)
leading to more blood loss. We report our experience in applying continuous Pringle maneuver with in situ
hypothermic perfusion via inferior mesenteric vein catheterization to the portal vein of the remnant liver for
resection during an extended left lobectomy of a large HCC which ruptured intraoperatively. Using this method, we
successfully managed the patient without any further morbidity. This technique provides easier accessibility of in
situ perfusion, decreases operative blood loss and prevents warm ischemic injury to the remnant liver during
parenchymal transection. This method could be effective for the resection of large ruptured HCC.
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Hepatic resection remains the optimal choice that offers
long-term survival for patients with hepatocellular carci-
noma (HCC). Various types of hepatic resection have been
created and modified over the years to achieve curative re-
section with adequate margins [1]. Remnant liver function
and operative blood loss are two major concerns during
hepatic resection. It can be calculated pre-operatively with
detailed imaging evaluation. There are various methods for
hepatic vascular control, namely, Pringle maneuver (PM),
in situ hypothermic perfusion (ISHP), and total hepatic
vascular exclusion (HVE) [2]. Intra-operative iatrogenic
rupture of HCC, which can occur during hepatic resection,
leads to adverse effects such as increased intra-operative
blood loss [3].
Hypothermic liver perfusion has been shown to atte-
nuate hepatic ischemic injury in large animals [4,5] and
humans [6,7]. The ISHP technique appears to be a useful
adjunct to radical hepatobiliary tumor excision, which
requires total HVE and major vascular reconstruction [8].* Correspondence: ufel4996@ms26.hinet.net
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reproduction in any medium, provided the orRecent studies have shown that continuous inflow occlu-
sion coupled with in situ liver cooling can be used safely,
even among patients with chronic liver disease [9,10].
Therefore, continuous inflow control plus ISHP is indi-
cated for large HCC, which can be associated with more
intra-operative blood loss and a longer operating time.
Herein, we report a case of an intra-operative rupture of
a large HCC that was resected using continuous PM with
ISHP via inferior mesenteric vein (IMV) catheterization.
We believe this is the first case report in English literature
about ISHP via IMV catheterization to the portal vein
(PV) of the remnant side.Case presentation
A 38-year-old man with history of chronic hepatitis B was
referred to our hospital for liver tumor management. The
triphasic helical computed tomography (CT) scan
revealed an 11-cm mass in segment 4 and 8 with early
enhancement and early washout and a thrombus was
detected in the left PV (Figure 1). Angiography disclosed
the main tumor and two additional tumors in the right
lobe. Preoperative laboratory data showed an indocyanine
green (ICG) test of 7.2%, aspartate aminotransferase
(AST) 63 U/L, alanine aminotransferase (ALT) 48 U/L,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Computed tomography (CT) scan images before
surgery. (A) Large liver tumor with diaphragmatic invasion and
occlusion of the middle hepatic vein. (B) Large liver tumor with
tumor thrombus in the left portal vein.
Figure 2 Intra-operative images. (A) Large liver tumor with
adhesion to the diaphragm and pericardium. (B) The transaction
surface after removal of the large liver tumor.
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(AFP) 303,145 ng/ml. The operative plan was to perform
an extended left lobectomy for the main tumor, followed
by transcatheter arterial embolization (TAE) for the right-
sided liver tumors.
Due to severe adhesion of the tumor to the surrounding
tissues, tumor rupture occurred during dissection. Com-
pression of the tumor and PM was applied immediately to
stop the bleeding. A long warm ischemic time was
expected for complex hepatectomy under PM. The main
PV was dissected and looped with a Rumel tourniquet;
following this, a cannula (8 French) was inserted into theright PV through a small venotomy in the IMV, and was
secured by a silk tie. Subsequently, the hilum was conti-
nuously clamped except for the right PV infusion of cold
4°C lactated Ringer’s solution, which was instituted at an
initial rate of 500 mL/h. The infusion rate was then
adjusted to keep the liver temperature between 26°C and
30°C, and the body temperature between 35°C and 37°C.
Parenchymal transection was carried out by using a com-
bination of techniques, including Kelly clamp fracturing
and a Cavitron Ultrasonic Surgical Aspirator (CUSA sys-
tem 200; Valleylab Inc., Boulder, CO, USA).
Parenchymal transection was aimed at achieving a 5 mm
resection margin. The average core liver temperature du-
ring ISHP measured by a needle probe (model YFi-100A,
Yu-Fong, Taiwan) placed at a depth of 2 to 3 cm into the
liver parenchyma of the remnant side was 27.9°C (range
26.0°C to 30.4°C). The mean body temperature was 36.0°C
(range 35.6°C to 36.3°C) during ISHP. The ISHP time was
90 minutes and the parenchymal transection time was
63 minutes. Blood loss was 800 mL. The total operation
time was 11 hours 34 minutes. The representative opera-
tive images are shown in Figure 2.
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ALT 267 U/L, and total bilirubin 3.1 mg/dL on post-
operative day (POD) 1; AST 145 U/L, ALT 164 U/L, and
total bilirubin 2.5 mg/dL on POD 2, and AST 84 U/L,
ALT 94 U/L, and total bilirubin 3.9 mg/dL on POD 3.
Liver function tests returned to baseline level on POD 5:
AST 53 U/L, ALT 47 U/L, and total bilrubin 1.3 mg/dL.
Peri-operative serum creatinine levels were within nor-
mal limits. The follow-up postoperative AFP level was
1488 ng/mL on POD 72. The postoperative clinical course
was uneventful and there were no major complications.
Figure 3 shows the postoperative image. Residual tumors
at the right side of the liver were managed by TAE after
complete recovery following surgery. Recurrent HCCs in
the remnant liver were detected 130 days after surgery
and were treated by additional TAE.
Discussion and conclusions
In this report, an intra-operative ruptured large HCC
was successfully managed by continuous PM with ISHP
via IMV catheterization. The technique of ISHP of the
liver was described by Fortner et al. in 1974 [11].
Hypothermia diminishes the metabolic rate, slows the
cellular degradation process of intracellular organs, and
decreases the lesions of membranes [12]. One study su-
ggests that when hypothermic perfusion is used in
addition to TVE, it provides significantly better tolerance
to ischemia, better liver function, and more importantly,
a significantly lower number of complications [12].
However, there is still debate about whether there is a
significant advantage of continuous PM coupled with
ISHP, over intermittent PM [13]. Some reports have
demonstrated that continuous inflow occlusion coupledFigure 3 Computed tomography (CT) scan image after surgery.with in situ liver cooling is a safe procedure with the
benefit of being able to prolong the ischemic time, even
for patients with chronic liver disease [9,10,13]. Lowe-
ring liver temperature between 26°C and 30°C allows the
procedure to go on for up to 140 minutes [13]. Torzilli
et al. [14] reported the safety of systematic prolonged
intermittent PM for hepatectomies exceeding 120 mi-
nutes. This report seems to be encouraging for extensive
liver resection; however, there is still concern about poor
tolerance of the ischemic insult to the liver with under-
lying disease. Hence, the resection method of large
HCC, which carries the possibility of major blood loss
and even tumor rupture, should be planned in detail be-
fore surgery.
When the in situ liver cooling method is used, cannula-
tion of the PV of the remnant side is usually performed
through a small venotomy near the bifurcation of the PV.
It is not uncommon for the catheter to be dislodged du-
ring liver mobilization for parenchymal transection. It is
difficult to perform venotomy for catheterization of the
PV under the Satinsky clamp during PM.
The IMV in the region of the bifurcation of the aorta
deviates to the left and upward as it passes beneath the
pancreas to join the splenic vein, and is easily identified
during laparotomy. According to our experience, the
major advantages of using the IMV for catheter place-
ment are easier accessibility and lower risk of catheter
dislodgement compared to management by means of PV
cannulation.
In conclusion, when dealing with large HCC, which may
carry the risk of more blood loss and longer transection
time, continuous PM with ISHP via IMV catheterization
to the remnant side may provide a suitable alternative
method for parenchymal transection.
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